# The Medicines (Products for Human Use– Fees) Amendment Regulations 1992, Regulation 11: Amendment of Schedule 4 to the principal Regulations


After paragraph 2 of Schedule 4 to the principal Regulations (time for payment of capital fees-applications made by small companies) there shall be inserted the following paragraph–
“2A In connection with an application for renewal of a product licence to which regulation 9A applies and in respect of which a fee is payable under paragraph (1) of that regulation, the fee shall, if the applicant so requests in writing, be payable as to 25% of the fee payable on the date on which the application for renewal is made and as to the remaining 75%, 12 months after that date or within 30 days following written notice from the licensing authority that the application has been determined, whichever shall be the earlier.”.

---
Source: https://www.legislation.gov.uk/uksi/1992/756/regulation/11 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-amendment-regulations-1992/regulation-11
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.